35 participants
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-04-19
- Start Date:
- 2023-02-16
- Completion:
- 2025-11-30
Conditions
- Cervical Cancer
Interventions
- DRUG
No Results Yet